Healthcare Reform to Benefit the US Generic Drug Market


The US generics sector is the fastest growing sector, both in terms of drug sales as well as prescriptions. All major generic drug companies have marked their presence in the US generic drug market and many more are planning to enter this market, thus increasing the competition in the market. According to our new research on the sector called “Booming US Generic Drug Market”, the generic drug market in the US is anticipated to grow at a CAGR of around 8.8% during 2010-2013.

There exists immense competition in the US generics industry. Moreover, the M&A activity has also increased in the sector, resulting in industry consolidation. At present, the sector is dominated by Israeli pharma major Teva Pharmaceuticals, followed by firms like Watson Pharmaceuticals and Mylan Labs. In this regard, our report provides complete information on the competitive landscape in the country.

It is seen that the political factor has played a major role in driving the future growth in the industry. Moreover, the healthcare reform by Obama government is also aimed at reducing the healthcare spending by promoting the use of generic drugs. This step will increase the demand of generics drugs in future, thus driving the future growth of the industry.

The report also studies and inter-relates various macroeconomic factors with the growth of industry to identify their impact on the future growth of the market. Besides, the disease statistics of the country has been included in the report along with the key therapies segments which have the highest potential for generic drugs.

“Booming US Generic Drug Market” gives an extensive and objective analysis on the generics drugs industry in the US. It features an analysis on the future directions of the market growth, supplemented with facts and figures. Thus, the report serves as a useful guide for pharma companies, consultants and investors who are planning to enter the Asia-Pacific pharma market.

For FREE SAMPLE of this report visit:


About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today’s globally competitive environment.

About the author

By rncos